Ocular hypertension, chronic open angle glaucoma, secondary glaucomas

Indication for Carteolol

Population group: Suitable for both men and women, only adults (18 years old or older)

For the reduction of intraocular pressure e.g. in ocular hypertension, chronic open angle glaucoma, some secondary glaucomas.

For this indication, competent medicine agencies globally authorize below treatments:

1-2 drops in 1-2 divided doses daily

Route of admnistration


Defined daily dose

1 - 2 {drops}

Dosage regimen

From 0.5 To 1 {drops} 2 time(s) per day every day

Detailed description

Initially one drop of 1% eye drops instilled twice daily in each affected eye. If the clinical response is not adequate the dosage may be altered to one drop of 2% eye drops twice daily in each affected eye.

Active ingredient

Carteolol is a non-selective beta-adrenergic blocking agent with associated intrinsic sympathomimetic activity (ISA) and without significant membrane stabilizing activity. Carteolol reduces normal and elevated intraocular pressure whether or not accompanied by glaucoma.

Read more about Carteolol

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner